GLYCEROGLYCOLIPID HAVING INFLUENZA VIRUS-BINDING ABILITY

PROBLEM TO BE SOLVED: To provide a new compound which has an ability for binding to influenza virus to neutralize the virus, to provide a method of producing the compound, to provide a new microorganism which has an ability of producing the compound, to provide a medicine which contains the compound...

Full description

Saved in:
Bibliographic Details
Main Authors SUZUKI YASUO, NAKADA KUNIO
Format Patent
LanguageEnglish
Published 11.09.2001
Edition7
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROCESSES USING MICROORGANISMS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
SUGARS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a new compound which has an ability for binding to influenza virus to neutralize the virus, to provide a method of producing the compound, to provide a new microorganism which has an ability of producing the compound, to provide a medicine which contains the compound as an active ingredient, and to provide a carrier obtained by binding the compounds. SOLUTION: Glyceroglycolipids H632A, S365A and S361A produced by microorganisms H632 strain, S365 strain, and S361 strain belonging to the genus Corynebacterium are provided.
Bibliography:Application Number: JP20000050440